机构:[1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China[2]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Institute for Stem Cell and Regenerative Medicine, Chinese Academy of Sciences, Beijing, 100101, China[4]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China[5]University of Chinese Academy of Sciences, Beijing, 100049, China
The authors appreciate the donation of ARPE-19 cells from Jiarui Li(Peking University People's Hospital). This work was supported by the National Key Research and Development Program (2018YFE0201100,2019YFA0110800,2020YFA0707900,201 9YFA0110100 and 2019YFA0903800); the CAS Project for Young Scientists in Basic Research (YSBR-012); the National Natural Science Foundation of China (32071456,82220108017, 82141128); The Capital Health Research and Development of Special (2020-1 -2052); Science & Technology Project of Beijing Municipal Science & Technology Commission
(Z201100005520045, Z181100001 818003).
第一作者机构:[1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China[3]Institute for Stem Cell and Regenerative Medicine, Chinese Academy of Sciences, Beijing, 100101, China[5]University of Chinese Academy of Sciences, Beijing, 100049, China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China[3]Institute for Stem Cell and Regenerative Medicine, Chinese Academy of Sciences, Beijing, 100101, China[4]Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China[5]University of Chinese Academy of Sciences, Beijing, 100049, China[*1]State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China
推荐引用方式(GB/T 7714):
Jiang Haiping,Chen Yuning,He Zhengquan,et al.Targeting non-muscle myosin II inhibits proliferative vitreoretinopathy through regulating epithelial-mesenchymal transition[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2023,686:149149.doi:10.1016/j.bbrc.2023.149149.
APA:
Jiang Haiping,Chen Yuning,He Zhengquan,Li Jie,Gao Qingqin...&Zhang Ying.(2023).Targeting non-muscle myosin II inhibits proliferative vitreoretinopathy through regulating epithelial-mesenchymal transition.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,686,
MLA:
Jiang Haiping,et al."Targeting non-muscle myosin II inhibits proliferative vitreoretinopathy through regulating epithelial-mesenchymal transition".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 686.(2023):149149